Repligen Corp

RGENNASDAQUSD
116.88 USD
0.90 (0.77%)🟢LIVE (AS OF 11:26 AM EDT)
🟢Market: OPEN
Open?$117.23
High?$119.29
Low?$114.64
Prev. Close?$117.78
Volume?112.0K
Avg. Volume?958.2K
VWAP?$116.72
Rel. Volume?0.12x
Bid / Ask
Bid?$115.00 × 100
Ask?$117.31 × 100
Spread?$2.31
Midpoint?$116.16
Valuation & Ratios
Market Cap?6.6B
Shares Out?56.3M
Float?55.9M
Float %?99.4%
P/E Ratio?135.70
P/B Ratio?3.15
EPS?$0.87
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?8.37Strong
Quick Ratio?7.12Strong
Cash Ratio?4.17Strong
Debt/Equity?0.26Low
ValuationRICHLY VALUED
Score
39/100
P/E?
135.7PRICEY
P/B?
3.15FAIR
P/S?
8.99HIGH
P/FCF?
70.7PRICEY
EV/EBITDA?
51.8HIGH
EV/Sales?
8.95HIGH
Returns & Efficiency
ROE?
2.3%WEAK
ROA?
1.7%WEAK
Cash Flow & Enterprise
FCF?$93.9M
Enterprise Value?$6.6B
Related Companies
Loading...
News
Profile
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Employees
2.0K
Market Cap
6.6B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1986-04-29
Address
41 SEYON STREET
WALTHAM, MA 02453
Phone: (781) 449-9560